Cancer as a complex phenotype: Pattern of cancer distribution within and beyond the nuclear family

PLoS Medicine

Volumn 1, Issue , 2004, Pages 229-236

  Amundadottir, Laufey T ^a   Thorvaldsson, Sverrir ^a   Gudbjartsson, Daniel F ^a   Sulem, Patrick ^a   Kristjansson, Kristleifur ^a   Arnason, Sigurdur ^a,c   Gulcher, Jeffrey R ^a   Bjornsson, Johannes ^b   Kong, Augustine ^a   Thorsteinsdottir, Unnur ^a   Stefansson, Kari ^a  

^a DECODE GENETICS   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^c Keflavik County Hospital   (Iceland)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER; CANCER LOCALIZATION; CANCER RISK; CONTROLLED STUDY; FAMILY; HEREDITY; HUMAN; ICELAND; MAJOR CLINICAL STUDY; PHENOTYPE; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; ADOLESCENT; ADULT; AGED; CHILD; ENVIRONMENT; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION; GENETICS; INFANT; MALE; MIDDLE AGED; NEOPLASM; NEWBORN; PEDIGREE; PRESCHOOL CHILD; REGISTER; RISK FACTOR; STATISTICS; THEORETICAL MODEL;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; ENVIRONMENT; FAMILY HEALTH; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ICELAND; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MODELS, THEORETICAL; NEOPLASMS; PEDIGREE; PHENOTYPE; REGISTRIES; RISK FACTORS;

EID: 13444268381     PISSN: 15491277     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pmed.0010065     Document Type: Article

References (48)

1. Anglian Breast Cancer Study Group (2000) Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group. Br J Cancer 83: 1301-1308.
2. Syrjakoski K, Vahteristo P, Eerola H, Tamminen A, Kivinummi K, et al. (2000) Population-based study of BRCA1 and BRCA2 mutations in 1035 unselected Finnish breast cancer patients. J Natl Cancer Inst 92: 1529-1531.
3. King MC, Marks JH, Mandell JB (2003) Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2. Science 302: 643-646.
4. Johannesdottir G, Gudmundsson J, Bergthorsson JT, Arason A, Agnarsson BA, et al. (1996) High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients. Cancer Res 56: 3663-3665.
5. Thorlacius S, Sigurdsson S, Bjarnadottir H, Olafsdottir G, Jonasson JG, et al. (1997) Study of a single BRCA2 mutation with high carrier frequency in a small population. Am J Hum Genet 60: 1079-1084.
6. Hartge P, Struewing JP, Wacholder S, Brody LC, Tucker MA (1999) The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews. Am J Hum Genet 64: 963-970.
7. Thorlacius S, Struewing JP, Hartge P, Olafsdottir GH, Sigvaldason H, et al. (1998) Population-based study of risk of breast cancer in carriers of BRCA2 mutation. Lancet 352: 1337-1339.
8. Dong C, Hemminki K (2001) Modification of cancer risks in offspring by sibling and parental cancers from 2,112,616 nuclear families. Int J Cancer 92: 144-150.
9. Vaittinen P, Hemminki K (1999) Familial cancer risks in offspring from discordant parental cancers. Int J Cancer 81: 12-19.
10. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86: 1600-1608.
11. Czene K, Lichtenstein P, Hemminki K (2002) Environmental and heritable causes of cancer among 9.6 million individuals in the Swedish Family-Cancer Database. Int J Cancer 99: 260-266.
12. Cannon-Albright LA, Thomas A, Goldgar DE, Gholami K, Rowe K, et al. (1994) Familiality of cancer in Utah. Cancer Res 54: 2378-2385.
13. Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA (1997) Family history and the risk of breast cancer: A systematic review and meta-analysis. Int J Cancer 71: 800-809.
14. Ziogas A, Gildea M, Cohen P, Bringman D, Taylor TH, et al. (2000) Cancer risk estimates for family members of a population-based family registry for breast and ovarian cancer. Cancer Epidemiol Biomarkers Prev 9: 103-111.
15. Tulinius H, Egilsson V, Olafsdottir GH, Sigvaldason H (1992) Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer. BMJ 305: 855-857.
16. Tulinius H, Olafsdottir GH, Sigvaldason H, Tryggvadottir L, Bjarnadottir K (1994) Neoplastic diseases in families of breast cancer patients. J Med Genet 31: 618-621.
17. Tulinius H, Sigvaldason H, Olafsdottir G, Tryggvadottir L, Bjarnadottir K (1999) Breast cancer incidence and familiality in Iceland during 75 years from 1921 to 1995. J Med Genet 36: 103-107.
18. Hrafnkelsson J, Tulinius H, Jonasson JG, Sigvaldason H (2001) Familial nonmedullary thyroid cancer in Iceland. J Med Genet 38: 189-191.
19. Gudbjartsson T, Jonasdottir TJ, Thoroddsen A, Einarsson GV, Jonsdottir GM, et al. (2002) A population-based familial aggregation analysis indicates genetic contribution in a majority of renal cell carcinomas. Int J Cancer 100: 476-479.
20. Tulinius H, Olafsdottir GH, Sigvaldason H, Arason A, Barkardottir RB, et al. (2002) The effect of a single BRCA2 mutation on cancer in Iceland. J Med Genet 39: 457-462.
21. Imsland AK, Eldon BJ, Arinbjarnarson S, Egilsson V, Tulinius H, et al. (2002) Genetic epidemiological aspects of gastric cancer in Iceland. J Am Coll Surg 195: 181-186.
22. Eldon BJ, Jonsson E, Tomasson J, Tryggvadottir L, Tulinius H (2003) Familial risk of prostate cancer in Iceland. BJU Int 92: 915-919.
23. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. (2000) Environmental and heritable factors in the causation of cancer-Analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78-85.
24. Thomas A, Cannon-Albright L, Bansal A, Skolnick MH (1999) Familial associations between cancer sites. Comput Biomed Res 32: 517-529.
25. Gholami K, Thomas A (1994) A linear time algorithm for calculation of multiple pairwise kinship coefficients and the genetic index of familiality. Comput Biomed Res 27: 342-350.
26. Gulcher JR, Kristjansson K, Gudbjartsson H, Stefansson K (2000) Protection of privacy by third-party encryption in genetic research in Iceland. Eur J Hum Genet 8: 739-742.
27. Moller B, Fekjaer H, Hakulinen T, Tryggvadottir L, Storm HH, et al. (2002) Prediction of cancer incidence in the Nordic countries up to the year 2020. Eur J Cancer Prev 11: S1-S96.
28. Jonasson JG, Tryggvadottir LT, Bjarnadottir K, Olafsdottir GH, Olafsdottir EJ, et al. (2002) Iceland. In: Parkin DM, SL Whelan SL, Ferlay J, Teppo L, Thomas DB, editors. Cancer incidence in five continents, Volume VIII (IARC Scientific Publications No. 143). Lyon: International Agency for Research on Cancer. pp. 354-355.
29. Gulcher J, Stefansson K (1998) Population genomics: Laying the groundwork for genetic disease modeling and targeting. Clin Chem Lab Med 36: 523-527.
30. Gulcher J, Kong A, Stefansson K (2001) The genealogic approach to human genetics of disease. Cancer J 7: 61-68.
31. Wallace C, Clayton D (2003) Estimating the relative recurrence risk ratio using a global cross-ratio model. Genet Epidemiol 25: 293-302.
32. Guo SW (1998) Inflation of sibling recurrence-risk ratio, due to ascertainment bias and/or overreporting. Am J Hum Genet 63: 252-258.
33. Sveinbjornsdottir S, Hicks AA, Jonsson T, Petursson H, Gugmundsson G, et al. (2000) Familial aggregation of Parkinson's disease in Iceland. N Engl J Med 343: 1765-1770.
34. Risch N (1990) Linkage strategies for genetically complex traits. I. Multilocus models. Am J Hum Genet 46: 222-228.
35. Risch N (1990) Linkage strategies for genetically complex traits. II. The power of affected relative pairs. Am J Hum Genet 46: 229-241.
36. Risch N (2001) The genetic epidemiology of cancer: Interpreting family and twin studies and their implications for molecular genetic approaches. Cancer Epidemiol Biomarkers Prev 10: 733-741.
37. Jonasson JG, Hrafnkelsson J, Bjornsson J (1989) Tumours in Iceland. 11. Malignant tumours of the thyroid gland. A histological classification and epidemiological considerations. Apmis 97: 625-630.
38. Hemminki K, Dong C, Vaittinen P (2001) Cancer risks to spouses and offspring in the Family-Cancer Database. Genet Epidemiol 20: 247-257.
39. Hemminki K, Jiang Y (2002) Cancer risks among long-standing spouses. Br J Cancer 86: 1737-1740.
40. Hemminki K, Chen B (2004) Familial risk for colorectal cancers are mainly due to heritable causes. Cancer Epidemiol Biomarkers Prev 13: 1253-1256.
41. Mellemgaard A, Jensen OM, Lynge E (1989) Cancer incidence among spouses of patients with colorectal cancer. Int J Cancer 44: 225-228.
42. Umar A, Boland CR, Terdiman JP, Syngal S, de la Chapelle A, et al. (2004) Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96: 261-268.
43. Oliveira Ferreira F, Napoli Ferreira CC, Rossi BM, Toshihiko Nakagawa W, Aguilar S Jr, et al. (2004) Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian hereditary colorectal cancer institutional registry. Fam Cancer 3: 41-47.
44. Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE (1994) Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 343: 692-695.
45. Breast Cancer Linkage Consortium (1999) Cancer risks in BRCA2 mutation carriers. The Breast Cancer Linkage Consortium. J Natl Cancer Inst 91: 1310-1316.
46. Baffoe-Bonnie AB, Kiemeney LA, Beaty TH, Bailey-Wilson JE, Schnell AH, et al. (2002) Segregation analysis of 389 Icelandic pedigrees with breast and prostate cancer. Genet Epidemiol 23: 349-363.
47. Loman N, Bladstrom A, Johannsson O, Borg A, Olsson H (2003) Cancer incidence in relatives of a population-based set of cases of early-onset breast cancer with a known BRCA1 and BRCA2 mutation status. Breast Cancer Res 5: R175-R186.
48. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J, editors (1997) Cancer incidence in five continents, Volume VII (IARC Scientific Publications No. 143). Lyon: International Agency for Research on Cancer. 1,240 p.